David Keefer's most recent trade in Dogwood Therapeutics Inc. was a trade of 2,362 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dogwood Therapeutics Inc. | David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,362 | 2,362 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 210 | 210 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 210 | 420 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 4,709 | 4,709 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | David Keefer | Director | Purchase of securities on an exchange or from another person at price $ 5.80 per share. | 04 Jan 2022 | 5,000 | 5,000 | - | 5.8 | 28,975 | Common Stock |
| Dogwood Therapeutics Inc. | David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 7,875 | 7,875 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | David Keefer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2021 | 1,602 | 0 | - | - | Warrant to Purchase Common Stock | |
| Dogwood Therapeutics Inc. | David Keefer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 28 Jan 2021 | 1,602 | 7,808 | - | 7.8 | 12,496 | Common Stock |